poloxalene has been researched along with Alzheimer Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agadjanyan, MG; Barrett, EG; Cotman, CW; Cribbs, DH; Das, P; Glabe, CC; Head, E; Kayed, R; Milgram, NW; Milton, S; Murphy, MP; Nistor, M; Sarsoza, F; Vasilevko, V | 1 |
1 other study(ies) available for poloxalene and Alzheimer Disease
Article | Year |
---|---|
Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Abeta.
Topics: Adjuvants, Immunologic; Alum Compounds; Alzheimer Disease; Alzheimer Vaccines; Amyloid beta-Peptides; Animals; Cerebral Cortex; Dogs; Enzyme-Linked Immunosorbent Assay; Epitope Mapping; Female; Histocytochemistry; Humans; Immunoglobulin G; Immunoglobulin M; Male; Models, Animal; Peptide Fragments; Poloxalene | 2006 |